Ugur Sahin is the head of Biontech and one of the first to bring a corona vaccine onto the market.
In an interview he talks about the long-awaited "antidote".
In the fight against the
coronavirus
, many are only waiting for one thing: the long-awaited
vaccine
.
The pioneer among
vaccine manufacturers
is the company
Biontech
from Mainz.
Chef Ugur Sahin
and his wife Özlem Türeci developed the “antidote”, which is already in use in Great Britain and the USA.
On Sunday, December 27, it should finally also in
Germany
with the
seeding
go * because the EU gave the green light for the vaccine.
echo24.de
* reports on it.
Vaccine against coronavirus from Biontech: boss Ugur Sahin on vaccination start
Shortly after the
approval of
the
corona vaccine was announced
,
bild.de
spoke
to Ugur Sahin.
"We are very happy that we
were able
to develop
an effective and well-tolerated
vaccine
in such a short time
with many, many people who work
together
in our
company
, but also with the many
cooperation partners
,
" said the 55-year-old .
But why does Germany have to wait five more days for the vaccine, why can't it start earlier?
According to
Sahin
, it takes this time because it is very much related to
logistics
.
The last tests also had to be carried out first.
"Every released drug batch must also be tested again."
According to the
Biontech boss, the
first trucks left
yesterday evening.
The
preparations
are in full swing, so that on Sunday, December 27th, the first
vaccinations
against the coronavirus will be available
can start.
Sahin himself has not yet been
vaccinated
against the
corona
virus and would like to wait until it is his turn.
However, his employees should be vaccinated as soon as possible so that
Covid-19
does not
hinder
the
production processes
and they can continue uninterrupted.
But when can the vaccine contain Covid-19 far enough so that a "normal" life is possible again?
First there should be enough
people
in Germany
get vaccinated - around 60 to 70 percent.
A return to normal life could then be the case in late summer 2021.
echo24.de explains how the vaccine works in the body *.
Biontech boss Ugur Sahin wants to produce 1.3 billion vaccine doses in 2021
The
vaccine
of
BioNTech
has been approved in 27 countries.
Therefore, more
vaccination doses have to be
produced
now
, because the demand is huge.
Another
production facility is to
open
in
Marburg
in the second quarter of 2021
.
The building is currently being remodeled.
Sahin hopes the authorities will
approve
the
manufacturing facility
as soon as possible.
Sahin plans to produce at least 1.3 billion vaccine doses in 2021.
There is also thought about how to make more
vaccine at Biontech
.
"But that requires extremely careful planning and cooperation with multiple companies, with cooperation partners from Germany in the USA with suppliers - that is a very complex matter and that is what we are currently very concerned about."
+
Ugur Sahin, CEO of Biontech (archive)
© Andreas Arnold / dpa
Corona mutation from England: Biontech has already tested 20 different mutations
A mutation of the coronavirus has occurred in Great Britain, with which, according to initial information, one can become infected even faster *.
What does this mean for the
vaccine
and the
hope
of a
return
to normal life?
"We have in the meantime more than 20 different
mutations
studied that have occurred over the past 10 months and each time have found that the effect of the
vaccine
is not affected." This test is now available with the new
virus
-
mutation
of
the UK
be performed.
Around the clock in shifts Sahin's team worked with BioNTech on the
development
of
Corona
-
vaccine
.
They knew when the
pandemic started
they could get the first
vaccine
on the market - and they did it.
At least in
Europe
.
* echo24.de is part of the Ippen-Digital network.
List of rubric lists: © Biontech / dpa